ZEO ScientifiXTM (ZEOX) is a research and manufacturing company specializing in biologic materials for investigational, regulated clinical environments, and for commercial distribution to licensed providers and institutions.
Operating in partnership with
Nova Southeastern University, Florida’s largest private research university, ZEO ScientifiX is headquartered within NSU’s Collaborative Center for Research. Our products are developed through controlled quality systems and rigorous release standards while supporting ongoing clinical research initiatives.
If you are a healthcare provider exploring compliant stem cell and EV options for orthopedics, pain management, or wound care, you can request pricing and ordering details below.
Advanced Solutions Formulated for Consistency
DayZero™ biologics are 100% non-fetal, non-embryonic materials collected from AABB-accredited tissue banks within hours of delivery to support time-sensitive handling and consistent starting material.
All donated tissue is screened, documented, and processed in an FDA-registered, cGMP facility, then cryopreserved under controlled conditions. Each lot ships with a certificate of analysis confirming sterility, identity, and post-thaw viability metrics, providing clinicians with documented, ethically sourced material and lot-level transparency.
Our DayZero line includes umbilical cord-derived stem cells, Wharton’s Jelly matrix with extracellular vesicles, and amniotic membrane patches in multiple configurations. We also offer Patient Pure X (PPX™), an autologous EV concentrate derived from the patient’s own blood and processed in an FDA-registered cGMP facility.
Each preparation includes release documentation with post-process counts and testing so clinics can verify key quality measures for each order.
Our Products
Umbilical Cord Stem Cells
DayZero™ umbilical cord-derived stem cells provide high live-cell counts for physicians in orthopedics, pain management, and advanced wound care.
Available in 10M and 20M vials; and in 100M, 120M, and 150M ready-to-use IV bags.
DayZero™ Exosomes
DayZero™ Exosomes offer a unique combination of perinatal tissue-derived extracellular vesicles and soluble paracrine factors.
Available in 150B, 250B and 500B (EV) vials (Therapeutic)
and 25B, 50B, and 100B vials (Aesthetic).
Patient Pure X™ (PPX™)
PPX is an autologous EV concentrate derived from a patient blood sample, processed in an FDA-registered cGMP facility, with release documentation including sterility testing and nanoparticle count.
Our proprietary sequence of centrifugation steps removes red blood cells and leukocytes while concentrating the platelet-derived extracellular vesicle fraction that carries growth factors and microRNA.
Wharton’s Jelly Matrix
This gelatinous scaffold combines a natural collagen and hyaluronic acid-rich
matrix with a dense EV payload.
Available in 50B, 100B, and 200B extracellular vesicles.
The ZEO Difference
Our products are positioned for investigational, research, and provider use where permitted, supported by documented quality standards and produced in FDA-registered facilities using cGMP-aligned processes.
The value is consistency: defined release criteria, ethical traceable sourcing, and batch-level documentation providers can verify.
- State of the Art research and manufacturing facility designed for consistency
- FDA registered as an HCT/P manufacturer
(21 CFR Part 1271) - cGMP-compliant processing facility
- ISO-7 Clean Room
- Independent third-party testing with a COA on every lot
Built for Compliance Reality
Regenerative medicine environment has changed. Regulations are more defined, scrutiny is higher, and the margin for error is smaller. ZEO supports qualified providers with product documentation, controlled processes, and an approach designed to align with this new evolving framework.
How to buy from us
Use the form below to send us your request. Our team will confirm your practice information, share current product availability and pricing context, and outline the ordering steps.
For PPX, the processing kit is shipped to the physician’s office for the blood draw and overnight return to the lab, and the finalized product is shipped back to the office after processing and release testing.
Tell us a bit about your practice and what you are evaluating. We will respond with the most relevant next step, whether that is product information, documentation, or a direct call with the team.
